Literature DB >> 20739895

Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.

Wei Zhang1, Yurong Gu, Youming Chen, Hong Deng, Lubiao Chen, Sui Chen, Genglin Zhang, Zhiliang Gao.   

Abstract

BACKGROUND/
PURPOSE: The intestinal microflora plays a major role in human health. Intestinal flora imbalances are seen in clinical settings, such as cirrhosis, in which bacterial translocation (BT) results in migration of bacteria or bacterial products from the intestinal lumen to extraintestinal sites. In this study, we explored the effect of alterations in gut flora on BT and liver function in cirrhotic rats.
METHODS: In this study, we used a carbon tetrachloride-induced cirrhotic rat model to compare the abundance of major aerobic and anaerobic bacterial species in healthy and cirrhotic rats. We used antibiotic (norfloxacin) and different probiotic treatments to change the status of gut flora in the cirrhotic rats and evaluated BT, liver function, and endotoxemia in the different models.
RESULTS: We found higher levels of Enterobacteriaceae in cirrhotic rats when compared with healthy rats. Bifidobacteria treatment resulted in lower levels of Enterobacteriaceae along with increased levels of Lactobacillus when compared with the normal saline group. Both Bifidobacteria and Enterococcus treatments resulted in lower endotoxin levels than in the normal saline group.
CONCLUSION: Gut flora imbalances in cirrhotic rats result in significant changes in BT and liver function in cirrhotic rats.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739895     DOI: 10.1097/MEG.0b013e32833eb8b0

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  25 in total

1.  Plasma Lipid Profiling in a Rat Model of Hepatocellular Carcinoma: Potential Modulation Through Quinolone Administration.

Authors:  Mohamed I F Shariff; Joshua M Tognarelli; Matthew R Lewis; Elizabeth J Want; Fatma El Zahra Mohamed; Nimzing G Ladep; Mary M E Crossey; Shahid A Khan; Rajiv Jalan; Elaine Holmes; Simon D Taylor-Robinson
Journal:  J Clin Exp Hepatol       Date:  2015-07-18

Review 2.  Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia.

Authors:  Hiroshi Fukui
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.

Authors:  Philipp Lutz; Hans Dieter Nischalke; Christian P Strassburg; Ulrich Spengler
Journal:  World J Hepatol       Date:  2015-03-27

4.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.

Authors:  Magdalena Mazagova; Lirui Wang; Andrew T Anfora; Max Wissmueller; Scott A Lesley; Yukiko Miyamoto; Lars Eckmann; Suraj Dhungana; Wimal Pathmasiri; Susan Sumner; Caroline Westwater; David A Brenner; Bernd Schnabl
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

5.  Lipopolysaccharide-induced bacterial translocation is intestine site-specific and associates with intestinal mucosal inflammation.

Authors:  Chao Yue; Bingqiang Ma; Yunzhao Zhao; Qiurong Li; Jieshou Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

Review 6.  Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

Authors:  Ekihiro Seki; Bernd Schnabl
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

7.  Lipopolysaccharide-induced failure of the gut barrier is site-specific and inhibitable by growth hormone.

Authors:  Chao Yue; Wei Wang; Wei-Liang Tian; Qian Huang; Ri-Sheng Zhao; Yun-Zhao Zhao; Qiu-Rong Li; Jie-Shou Li
Journal:  Inflamm Res       Date:  2013-01-23       Impact factor: 4.575

8.  Probiotic and lactulose: influence on gastrointestinal flora and pH value in minimal hepatic encephalopathy rats.

Authors:  Shu-Man Jiang; Lin Jia; Mei-Hua Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition.

Authors:  Ming Li; Lin Zhu; Ao Xie; Jieli Yuan
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

Review 10.  Changes of Intestinal Functions in Liver Cirrhosis.

Authors:  Hiroshi Fukui; Reiner Wiest
Journal:  Inflamm Intest Dis       Date:  2016-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.